|
1.
|
Meyer TE, Shih J. The conundrum of worsening renal function and optimal volume status in patients with acute decompensated heart failure. Curr Heart Fail Rep. 2010 Dec; 7(4):149-52.
|
|
|
|
|
2.
|
Chinali M, Joffe SW, Aurigemma GP, Makam R, Meyer TE, Goldberg RJ. Risk factors and comorbidities in a community-wide sample of patients hospitalized with acute systolic or diastolic heart failure: the Worcester Heart Failure Study. Coron Artery Dis. 2010 May; 21(3):137-43.
|
|
|
|
|
3.
|
Narayanan A, Aurigemma GP, Chinali M, Hill JC, Meyer TE, Tighe DA. Cardiac mechanics in mild hypertensive heart disease: a speckle-strain imaging study. Circ Cardiovasc Imaging. 2009 Sep; 2(5):382-90.
|
|
|
|
|
4.
|
Fitzgibbons TP, Madias C, Seth A, Bouchard JL, Kuvin JT, Patel AR, Pandian NG, Meyer TE, Aurigemma GP, Tighe DA. Prevalence and clinical characteristics of right ventricular dysfunction in transient stress cardiomyopathy. Am J Cardiol. 2009 Jul 1; 104(1):133-6.
|
|
|
|
|
5.
|
Fitzgibbons TP, Meyer TE, Aurigemma GP. Mortality in diastolic heart failure: an update. Cardiol Rev. 2009 Mar-Apr; 17(2):51-5.
|
|
|
|
|
6.
|
Gaasch WH, Meyer TE. Left ventricular response to mitral regurgitation: implications for management. Circulation. 2008 Nov 25; 118(22):2298-303.
|
|
|
|
|
7.
|
Hurlburt HM, Aurigemma GP, Hill JC, Narayanan A, Gaasch WH, Vinch CS, Meyer TE, Tighe DA. Direct ultrasound measurement of longitudinal, circumferential, and radial strain using 2-dimensional strain imaging in normal adults. Echocardiography. 2007 Aug; 24(7):723-31.
|
|
|
|
|
8.
|
Bouchard JL, Aurigemma GP, Goldberg RJ, Fournier JB, Vinch CS, Hill JC, Ennis CA, Tighe DA, Meyer TE. Heart failure in the "oldest old": clinical and echocardiographic insights. Am J Geriatr Cardiol. 2007 Jul-Aug; 16(4):236-42.
|
|
|
|
|
9.
|
Meyer TE. Sustained reversal of left ventricular remodeling following mechanical and pharmacologic therapy. Curr Cardiol Rep. 2007 May; 9(3):221-3.
|
|
|
|
|
10.
|
Goldberg RJ, Ciampa J, Lessard D, Meyer TE, Spencer FA. Long-term survival after heart failure: a contemporary population-based perspective. Arch Intern Med. 2007 Mar 12; 167(5):490-6.
|
|
|
|
|
11.
|
Perlini S, Arosio B, Parmeggiani L, Santambrogio D, Palladini G, Tozzi R, Gatti C, Annoni G, Meyer TE, Ferrari AU. Adenosine A1 receptor expression during the transition from compensated pressure overload hypertrophy to heart failure. J Hypertens. 2007 Feb; 25(2):449-54.
|
|
|
|
|
12.
|
Goldberg RJ, Spencer FA, Farmer C, Lessard D, Pezzella SM, Meyer TE. Use of disease-modifying therapies in patients hospitalized with heart failure: a population-based perspective. Am J Med. 2007 Jan; 120(1):98.e1-8.
|
|
|
|
|
13.
|
Meyer TE. The ESCAPE trial. Curr Cardiol Rep. 2006 May; 8(3):201-3.
|
|
|
|
|
14.
|
Goldberg RJ, Farmer C, Spencer FA, Pezzella S, Meyer TE. Use of nonpharmacologic treatment approaches in patients with heart failure. Int J Cardiol. 2006 Jun 28; 110(3):348-53.
|
|
|
|
|
15.
|
Vinch CS, Aurigemma GP, Simon HU, Hill JC, Tighe DA, Meyer TE. Analysis of left ventricular systolic function using midwall mechanics in patients >60 years of age with hypertensive heart disease and heart failure. Am J Cardiol. 2005 Nov 1; 96(9):1299-303.
|
|
|
|
|
16.
|
Spencer FA, Meyer T. Heart failure and shock complicating acute coronary syndromes. Curr Cardiol Rep. 2005 Jul; 7(4):276-82.
|
|
|
|
|
17.
|
Goldberg RJ, Spencer FA, Farmer C, Meyer TE, Pezzella S. Incidence and hospital death rates associated with heart failure: a community-wide perspective. Am J Med. 2005 Jul; 118(7):728-34.
|
|
|
|
|
18.
|
Goldberg RJ, Glatfelter K, Burbank-Schmidt E, Farmer C, Spencer FA, Meyer T. Trends in mortality attributed to heart failure in Worcester, Massachusetts, 1992 to 2001. Am J Cardiol. 2005 Jun 1; 95(11):1324-8.
|
|
|
|
|
19.
|
Meyer TE. Nitric oxide donor therapy for patients with heart failure. Curr Cardiol Rep. 2005 May; 7(3):193-4; discussion 194.
|
|
|
|
|
20.
|
Meyer TE. Catheter ablation for atrial fibrillation in heart failure patients. Curr Cardiol Rep. 2005 May; 7(3):194-5; discussion 195.
|
|
|
|
|
21.
|
Vinch CS, Hill JC, Logsetty G, Tighe DA, Meyer TE, Aurigemma GP. Paradoxical changes in brain natriuretic peptide levels and loading conditions after intravenous conscious sedation. J Am Soc Echocardiogr. 2004 Nov; 17(11):1191-6.
|
|
|
|
|
22.
|
Lorbar M, Chung ES, Nabi A, Skalova K, Fenton RA, Dobson JG, Meyer TE. Receptors subtypes involved in adenosine-mediated modulation of norepinephrine release from cardiac nerve terminals. Can J Physiol Pharmacol. 2004 Nov; 82(11):1026-31.
|
|
|
|
|
23.
|
Vinch CS, Rashkin J, Logsetty G, Tighe DA, Hill JC, Meyer TE, Rosenthal LS, Aurigemma GP. Brain natriuretic peptide levels fall rapidly after cardioversion of atrial fibrillation to sinus rhythm. Cardiology. 2004; 102(4):188-93.
|
|
|
|
|
24.
|
Meyer TE. The candesartan in heart failure-assessment of reduction in mortality and morbidity-preserved trial. Curr Cardiol Rep. 2004 May; 6(3):197-8.
|
|
|
|
|
25.
|
Meyer TE. The carvedilol or metoprolol European trial. Curr Cardiol Rep. 2004 May; 6(3):198-9.
|
|
|
|
|
26.
|
Meyer TE. Anemia in heart failure. Curr Cardiol Rep. 2003 May; 5(3):213-4.
|
|
|
|
|
27.
|
Meyer TE. B-type natriuretic peptide in the diagnosis of heart failure. Curr Cardiol Rep. 2003 May; 5(3):214-5.
|
|
|
|
|
28.
|
Vinch CS, Aurigemma GP, Hill JC, Gaasch WH, Volturo G, Tighe DA, Meyer TE. Usefulness of clinical variables, echocardiography, and levels of brain natriuretic peptide and norepinephrine to distinguish systolic and diastolic causes of acute heart failure. Am J Cardiol. 2003 May 1; 91(9):1140-3.
|
|
|
|
|
29.
|
Tighe DA, Vinch CS, Hill JC, Meyer TE, Goldberg RJ, Aurigemma GP. Influence of age on assessment of diastolic function by Doppler tissue imaging. Am J Cardiol. 2003 Jan 15; 91(2):254-7.
|
|
|
|
|
30.
|
Seth PS, Aurigemma GP, Krasnow JM, Tighe DA, Untereker WJ, Meyer TE. A syndrome of transient left ventricular apical wall motion abnormality in the absence of coronary disease: a perspective from the United States. Cardiology. 2003; 100(2):61-6.
|
|
|
|
|
31.
|
Botkin NF, Aurigemma GP, Meyer TE, Tighe DA. Periprosthetic aortic valve ring abscess. Echocardiography. 2002 Oct; 19(7 Pt 1):569-70.
|
|
|
|
|
32.
|
Spencer FA, Meyer TE, Gore JM, Goldberg RJ. Heterogeneity in the management and outcomes of patients with acute myocardial infarction complicated by heart failure: the National Registry of Myocardial Infarction. Circulation. 2002 Jun 4; 105(22):2605-10.
|
|
|
|
|
33.
|
Norton GR, Woodiwiss AJ, Gaasch WH, Mela T, Chung ES, Aurigemma GP, Meyer TE. Heart failure in pressure overload hypertrophy. The relative roles of ventricular remodeling and myocardial dysfunction. J Am Coll Cardiol. 2002 Feb 20; 39(4):664-71.
|
|
|
|
|
34.
|
Aurigemma GP, Ronen A, Cuénoud H, Folland ED, Meyer TE. Severe mitral valve regurgitation associated with dexfenfluramine use. Cardiology. 2002; 98(4):215-7.
|
|
|
|
|
35.
|
Brand MD, Abadi CA, Aurigemma GP, Dauerman HL, Meyer TE. Radiation-associated valvular heart disease in Hodgkin's disease is associated with characteristic thickening and fibrosis of the aortic-mitral curtain. J Heart Valve Dis. 2001 Sep; 10(5):681-5.
|
|
|
|
|
36.
|
Lorbar M, Skalova K, Nabi A, Chung ES, Fenton RA, Dobson JG, Meyer TE. Norepinephrine concentrations in the epicardial transudate reflect early changes in adrenergic activity in the isolated perfused heart. J Mol Cell Cardiol. 2000 Sep; 32(9):1695-701.
|
|
|
|
|
37.
|
Fenton RA, Dickson EW, Meyer TE, Dobson JG. Aging reduces the cardioprotective effect of ischemic preconditioning in the rat heart. J Mol Cell Cardiol. 2000 Jul; 32(7):1371-5.
|
|
|
|
|
38.
|
Hanna SR, Chung ES, Aurigemma GP, Meyer TE. Worsening of mitral regurgitation secondary to ventricular pacing. J Heart Valve Dis. 2000 Mar; 9(2):273-5.
|
|
|
|
|
39.
|
Spencer FA, Meyer TE, Goldberg RJ, Yarzebski J, Hatton M, Lessard D, Gore JM. Twenty year trends (1975-1995) in the incidence, in-hospital and long-term death rates associated with heart failure complicating acute myocardial infarction: a community-wide perspective. J Am Coll Cardiol. 1999 Nov 1; 34(5):1378-87.
|
|
|
|
|
40.
|
Mela T, Meyer TE, Pape LA, Chung ES, Aurigemma GP, Weiner BH. Coronary arterial dimension-to-left ventricular mass ratio in idiopathic dilated cardiomyopathy. Am J Cardiol. 1999 Apr 15; 83(8):1277-80, A9.
|
|
|
|
|
41.
|
Aurigemma GP, Meyer TE, Sharma M, Sweeney A, Gaasch WH. Evaluation of extent of shortening versus velocity of shortening at the endocardium and midwall in hypertensive heart disease. Am J Cardiol. 1999 Mar 1; 83(5):792-4, A10.
|
|
|
|
|
42.
|
Chung ES, Perlini S, Aurigemma GP, Fenton RA, Dobson JG, Meyer TE. Effects of chronic adenosine uptake blockade on adrenergic responsiveness and left ventricular chamber function in pressure overload hypertrophy in the rat. J Hypertens. 1998 Dec; 16(12 Pt 1):1813-22.
|
|
|
|
|
43.
|
Perlini S, Khoury EP, Norton GR, Chung ES, Fenton RA, Dobson JG, Meyer TE. Adenosine mediates sustained adrenergic desensitization in the rat heart via activation of protein kinase C. Circ Res. 1998 Oct 5; 83(7):761-71.
|
|
|
|
|
44.
|
Sharma M, Aurigemma GP, Meyer TE, Gaasch WH. Recurrent syncope after successful aortic valve replacement. Am Heart J. 1996 Jul; 132(1 Pt 1):194-7.
|
|
|
|
|
45.
|
Aurigemma GP, Gaasch WH, McLaughlin M, McGinn R, Sweeney A, Meyer TE. Reduced left ventricular systolic pump performance and depressed myocardial contractile function in patients > 65 years of age with normal ejection fraction and a high relative wall thickness. Am J Cardiol. 1995 Oct 1; 76(10):702-5.
|
|
|
|
|
46.
|
Aurigemma GP, Gaasch WH, Villegas B, Meyer TE. Noninvasive assessment of left ventricular mass, chamber volume, and contractile function. Curr Probl Cardiol. 1995 Jun; 20(6):361-440.
|
|
|
|
|
47.
|
Meyer TE, Föex P, Ryder WA. Effect of critical coronary stenosis on regional function of a segment remote from the acute ischemic bed. Coron Artery Dis. 1994 Jun; 5(6):471-9.
|
|
|
|
